Form 4: KORU Medical Systems Director Boosts Stake with Share Acquisition
Insider Transaction Report
KORU Medical Systems, Inc. Director Matin Shahriar acquired 4,189 shares of common stock at $3.58 per share, increasing his direct beneficial ownership to 87,604 shares.
Summary
- Matin Shahriar, a Director of KORU Medical Systems, Inc. (KRMD), acquired 4,189 shares of common stock.
- The transaction occurred on July 2, 2025, at a price of $3.58 per share.
- Following this acquisition, Matin Shahriar directly beneficially owns a total of 87,604 shares of KORU Medical Systems, Inc. common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase.
Sentiment
Score: 8
Explanation: The acquisition of shares by a director is a strong positive signal, indicating insider confidence in the company's future prospects and valuation.
Positives
- A director's acquisition of shares signals confidence in the company's future prospects and valuation.
- The increase in direct beneficial ownership by a key insider aligns the director's interests more closely with those of shareholders.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This insider transaction reflects an individual director's investment decision and does not directly provide broader industry trends or competitive analysis. However, insider buying can sometimes be a leading indicator of management's perception of the company's position within its industry.
Related Party Transactions
- The reported transaction is a related party transaction, as it involves a director of the company acquiring shares.
Stakeholder Impact
- Shareholders: The director's purchase may instill confidence among existing and potential shareholders, suggesting that insiders believe the stock is undervalued or has significant upside potential.
Key Dates
| Date | Description |
|---|---|
| 07/02/2025 | Date of common stock acquisition by Director Matin Shahriar. |
Recommendation
buyKeywords
KORU Medical Systems, KRMD, Matin Shahriar, Director, Insider Trading, Form 4, Stock Acquisition, Share Purchase, Beneficial Ownership, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.